buformin has been researched along with Atherosclerotic Parkinsonism in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martà Massó, JF | 1 |
| Carrera, N | 1 |
| Urtasun, M | 1 |
1 other study available for buformin and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Drug-induced parkinsonism: a growing list.
Topics: Aged; Antiemetics; Aprindine; Benzamides; Buformin; Female; Humans; Male; Middle Aged; Parkinson Dis | 1993 |